+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Buccal Drug Delivery Systems Market by Product Type (Films, Gels, Patches), Drug Class (Analgesics, Cardiovascular, Central Nervous System), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Buccal Drug Delivery Systems Market by Product Type (Films, Gels, Patches), Drug Class (Analgesics, Cardiovascular, Central Nervous System), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Buccal Drug Delivery Systems Market by Product Type (Films, Gels, Patches), Drug Class (Analgesics, Cardiovascular, Central Nervous System), Application, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011476
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Buccal Drug Delivery Systems Market grew from USD 2.43 billion in 2024 to USD 2.67 billion in 2025. It is expected to continue growing at a CAGR of 9.44%, reaching USD 4.18 billion by 2030.

Comprehensive Overview of Buccal Drug Delivery Systems Highlighting Significance Applications and Recent Innovations Transforming Patient Outcomes

The growing demand for targeted, noninvasive therapeutic delivery has positioned buccal drug administration at the forefront of pharmaceutical innovation. By leveraging the rich vascularization of the oral mucosa, these systems enable rapid onset of action and bypass first-pass metabolism, offering significant advantages over traditional oral or injectable routes.

Recent research has introduced novel polymer matrices, mucoadhesive films, and precision spray technologies that enhance bioavailability and patient comfort. This convergence of material science and formulation expertise is driving a wave of new applications, from pain management to hormone therapy, reshaping perceptions of convenience and efficacy.

As we embark on this comprehensive examination, it is essential to understand both the technological foundations and evolving clinical needs that underpin the expansion of buccal drug delivery. This introduction sets the stage for an in-depth analysis of key market drivers, regulatory influences, and actionable insights.

Exploration of Transformative Shifts in the Buccal Delivery Landscape Driven by Technological Advances Regulatory Evolutions and Patient-Centric Innovations

The buccal delivery landscape is undergoing transformative shifts fueled by breakthroughs in polymer engineering and digital formulation tools. Advanced mucoadhesive materials now permit controlled release profiles tailored to therapeutic windows, thereby ensuring optimized dosing regimens and improved patient adherence.

Concurrently, regulatory agencies have introduced guidance frameworks that emphasize quality by design and real-time monitoring of critical formulation parameters. This regulatory evolution is accelerating the adoption of robust manufacturing protocols, while also encouraging collaborative partnerships between industry and academia to expedite clinical translation.

Moreover, patient-centric considerations are catalyzing innovations in dosage form design. User-friendly films and discreet single-actuation sprays are redefining ease of use, particularly for chronic therapies where sustained adherence is crucial. These shifts collectively highlight a dynamic ecosystem in which technological prowess and regulatory clarity converge to redefine therapeutic delivery.

Assessment of the Cumulative Impact of New United States Tariffs in 2025 on Buccal Drug Delivery Supply Chains Costs and Competitive Dynamics

The introduction of new United States tariffs in 2025 has reverberated across buccal drug delivery supply chains, intensifying scrutiny of raw material sourcing and cost structures. Key polymer derivatives and specialized excipients, often imported from global hubs, now carry elevated tariffs, prompting formulators to reevaluate vendor agreements and material substitutions.

In response, several manufacturers have accelerated near-shoring initiatives, establishing regional production nodes to mitigate tariff impacts and ensure continuity of supply. These strategic shifts are complemented by forward contracts and collaborative procurement pools that leverage collective buying power, thereby cushioning cost volatility.

Despite short-term cost pressures, the industry is seizing this challenge as an impetus for supply chain resilience. Through closer partnerships with domestic suppliers and investment in localized R&D, organizations are laying the groundwork for a more agile, vertically integrated buccal delivery ecosystem.

Insightful Examination of Market Segmentation Revealing How Product Types Drug Classes Applications End Users and Distribution Channels Shape Growth Drivers

Analyzing the market through a product type lens reveals five dominant dosage forms that cater to diverse clinical needs. Films, segmented into cellulose derivatives, natural polymers, and synthetic polymers, deliver targeted adhesion and controlled release with further granularity in hydroxypropyl methylcellulose and microcrystalline cellulose variants. Gels, encompassing hydrogels and organogels, offer versatile rheological properties for both local and systemic therapies. Patches, divided between adhesive and matrix formats, support sustained drug delivery, while multi-actuation and single-actuation sprays provide precise dosing for rapid mucosal absorption. Tablets, from chewable lozenges to mucoadhesive formats, continue to evolve in texture and dissolution profiles.

A drug class perspective underscores the prominence of analgesics such as buprenorphine and fentanyl, alongside cardiovascular agents like nitroglycerin, and hormone therapies centered on estradiol and testosterone. Central nervous system treatments and novel psychotropic compounds are also gaining traction, expanding the therapeutic scope of buccal delivery.

When viewed by application, the market spans cardiovascular treatment, hormone therapy, pain management, and psychiatry, each reflecting tailored formulation requirements and patient adherence considerations. End users range from clinical settings and hospitals to at-home care environments, shaping product design and packaging approaches. Distribution channels, including hospital pharmacies, online pharmacies, and retail outlets, further inform go-to-market strategies and patient accessibility.

Detailed Regional Insights Showcasing Distinct Drivers Opportunities and Challenges Across Americas Europe Middle East Africa and Asia Pacific Markets

In the Americas, robust healthcare infrastructure and a favorable reimbursement environment have accelerated the uptake of advanced buccal formulations, particularly for opioid and hormone therapies. Emerging partnerships between biotech firms and academic centers are fostering next-generation mucoadhesive platforms with enhanced patient adherence metrics.

In Europe, the Middle East, and Africa, regulatory harmonization initiatives are streamlining approval pathways, enabling faster entry for novel dosage forms. Local manufacturers are also collaborating with multinational firms to address region-specific therapeutic demands, from pain management in aging populations to hormone replacement therapies.

Across Asia-Pacific, expanding healthcare access and rising disposable incomes are driving demand for convenient, self-administered buccal products. Governments are incentivizing domestic innovation through research grants, while contract development and manufacturing organizations are scaling capabilities to serve both regional and global markets.

Strategic Analysis of Leading Companies Unveiling Competitive Strategies Partnerships Product Portfolios and Innovation Pipelines Driving Market Leadership

Leading companies are deploying diversified strategies to secure competitive advantage in buccal drug delivery. Some are forging cross-sector alliances to co-develop advanced polymer matrices and digital dosing platforms, thereby bridging material science expertise with data analytics capabilities.

Others are expanding their product portfolios through targeted acquisitions of specialized formulation assets and patent estates, reinforcing their pipelines in high-value segments such as pain management and hormone therapy. Continuous investment in clinical trials and bioequivalence studies is further underpinning product differentiation and market exclusivity.

Innovation pipelines are also being bolstered by collaborations with academic research centers and technology accelerators, focusing on novel excipient chemistries and wearable buccal systems. This strategic mosaic of partnerships and in-house R&D is defining the future competitive landscape.

Actionable Recommendations for Industry Leaders to Capitalize on Emerging Trends Optimize Operations and Accelerate Growth in Buccal Drug Delivery Markets

Industry leaders should prioritize end-to-end supply chain transparency by integrating digital tracking systems for critical excipients, thereby reducing tariff-related risks and ensuring rapid response to regulatory changes. Concurrently, strategic alliances with domestic raw material suppliers can foster co-development of alternative polymers, mitigating import dependencies.

Investing in modular manufacturing platforms that support multiple buccal formats will enable agile reprioritization of production lines in response to shifting therapeutic demands. Aligning these capabilities with patient-centric design principles-such as taste masking and flexible dosing-is essential to drive adoption in both clinical and home care settings.

Finally, cultivating data-driven insights through real-world evidence programs will bolster market positioning by demonstrating enhanced patient outcomes and adherence metrics. This evidence will also facilitate broader reimbursement discussions, ultimately supporting sustained market growth.

Thorough Research Methodology Underpinning Comprehensive Analysis Including Data Sources Analytical Frameworks and Validation Techniques for Robust Findings

This analysis is underpinned by a multi-stage research methodology that integrates both primary and secondary data. Structured interviews were conducted with key opinion leaders in pharmaceutical R&D, supply chain management, and regulatory affairs to capture firsthand insights into formulation challenges and market dynamics.

Secondary sources include peer-reviewed journals, patent databases, and company publications, which were systematically reviewed to validate technological trends and competitive strategies. Data triangulation techniques were employed to ensure consistency across multiple information streams.

Finally, all findings were subjected to rigorous internal validation processes, leveraging expert review panels to confirm the accuracy and relevance of strategic imperatives. This comprehensive methodology ensures that the conclusions and recommendations presented are robust and actionable.

Conclusive Synthesis Highlighting Key Takeaways Critical Insights and Strategic Imperatives From Buccal Drug Delivery Market Research

Through a detailed examination of technological innovations, regulatory shifts, and geopolitical influences, this research highlights the dynamic evolution of buccal drug delivery systems. Key segmentation insights reveal how product formats, drug classes, and distribution channels converge to address diverse therapeutic needs.

Regional analyses underscore the importance of localized strategies and partnerships, while competitive intelligence on leading companies illuminates the strategic imperatives shaping market leadership. The cumulative impact of new tariffs has catalyzed resilience initiatives that will likely define supply chain architectures in the coming years.

Collectively, these insights equip decision-makers with a nuanced understanding of the landscape, enabling targeted investments, strategic collaborations, and evidence-based product development that will drive the next wave of growth in buccal delivery.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Films
      • Cellulose Derivatives
        • Hydroxypropyl Methylcellulose
        • Microcrystalline Cellulose
      • Natural Polymers
      • Synthetic Polymers
    • Gels
      • Hydrogels
      • Organogels
    • Patches
      • Adhesive Patches
      • Matrix Patches
    • Sprays
      • Multi Actuation
      • Single Actuation
    • Tablets
      • Chewable Tablets
      • Lozenges
      • Mucoadhesive Tablets
  • Drug Class
    • Analgesics
      • Buprenorphine
      • Fentanyl
    • Cardiovascular
      • Nitroglycerin
    • Central Nervous System
    • Hormones
      • Estradiol
      • Testosterone
  • Application
    • Cardiovascular Treatment
    • Hormone Therapy
    • Pain Management
    • Psychiatry
  • End User
    • Clinics
    • Home Care
    • Hospitals
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • GlaxoSmithKline plc
  • Novartis AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Bausch Health Companies Inc.
  • BioDelivery Sciences International, Inc.
  • Roche Holding AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancement in mucoadhesive nanoparticle formulations for enhanced buccal drug bioavailability
5.2. Application of 3D printing technologies to customize buccal film dosage forms for personalized therapy
5.3. Exploration of permeation enhancers to optimize drug absorption through buccal mucosa membranes
5.4. Development of sustained-release buccal adhesive gels for chronic pain management therapies
5.5. Use of wireless sensors in buccal patches for real-time monitoring of patient drug compliance
5.6. Implementation of cyclic peptide-based carriers to improve stability of buccal vaccine delivery
5.7. Regulatory challenges and harmonization efforts impacting novel buccal drug delivery approvals
5.8. Growth in chronic disease management using transbuccal delivery of peptide and small molecule drugs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Buccal Drug Delivery Systems Market, by Product Type
8.1. Introduction
8.2. Films
8.2.1. Cellulose Derivatives
8.2.1.1. Hydroxypropyl Methylcellulose
8.2.1.2. Microcrystalline Cellulose
8.2.2. Natural Polymers
8.2.3. Synthetic Polymers
8.3. Gels
8.3.1. Hydrogels
8.3.2. Organogels
8.4. Patches
8.4.1. Adhesive Patches
8.4.2. Matrix Patches
8.5. Sprays
8.5.1. Multi Actuation
8.5.2. Single Actuation
8.6. Tablets
8.6.1. Chewable Tablets
8.6.2. Lozenges
8.6.3. Mucoadhesive Tablets
9. Buccal Drug Delivery Systems Market, by Drug Class
9.1. Introduction
9.2. Analgesics
9.2.1. Buprenorphine
9.2.2. Fentanyl
9.3. Cardiovascular
9.3.1. Nitroglycerin
9.4. Central Nervous System
9.5. Hormones
9.5.1. Estradiol
9.5.2. Testosterone
10. Buccal Drug Delivery Systems Market, by Application
10.1. Introduction
10.2. Cardiovascular Treatment
10.3. Hormone Therapy
10.4. Pain Management
10.5. Psychiatry
11. Buccal Drug Delivery Systems Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Buccal Drug Delivery Systems Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Americas Buccal Drug Delivery Systems Market
13.1. Introduction
13.2. Mexico
13.3. United States
13.4. Canada
13.5. Argentina
13.6. Brazil
14. Europe, Middle East & Africa Buccal Drug Delivery Systems Market
14.1. Introduction
14.2. Finland
14.3. Netherlands
14.4. Spain
14.5. Norway
14.6. Germany
14.7. Italy
14.8. Denmark
14.9. United Kingdom
14.10. Turkey
14.11. United Arab Emirates
14.12. Saudi Arabia
14.13. France
14.14. Sweden
14.15. Russia
14.16. Switzerland
14.17. Poland
14.18. Nigeria
14.19. South Africa
14.20. Egypt
14.21. Qatar
14.22. Israel
15. Asia-Pacific Buccal Drug Delivery Systems Market
15.1. Introduction
15.2. India
15.3. Thailand
15.4. Taiwan
15.5. Singapore
15.6. Malaysia
15.7. Australia
15.8. South Korea
15.9. Indonesia
15.10. China
15.11. Philippines
15.12. Vietnam
15.13. Japan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Novartis AG
16.3.3. Johnson & Johnson
16.3.4. Pfizer Inc.
16.3.5. Bayer AG
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.7. Viatris Inc.
16.3.8. Bausch Health Companies Inc.
16.3.9. BioDelivery Sciences International, Inc.
16.3.10. Roche Holding AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BUCCAL DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BUCCAL DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BUCCAL DRUG DELIVERY SYSTEMS MARKET: RESEARCHAI
FIGURE 26. BUCCAL DRUG DELIVERY SYSTEMS MARKET: RESEARCHSTATISTICS
FIGURE 27. BUCCAL DRUG DELIVERY SYSTEMS MARKET: RESEARCHCONTACTS
FIGURE 28. BUCCAL DRUG DELIVERY SYSTEMS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BUCCAL DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORGANOGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORGANOGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ADHESIVE PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ADHESIVE PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MULTI ACTUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MULTI ACTUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SINGLE ACTUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SINGLE ACTUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CHEWABLE TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LOZENGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LOZENGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MUCOADHESIVE TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY MUCOADHESIVE TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FENTANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NITROGLYCERIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NITROGLYCERIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ESTRADIOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ESTRADIOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TESTOSTERONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PSYCHIATRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 162. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 163. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 204. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 205. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 206. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 207. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 208. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 209. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 210. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 211. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 212. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 213. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 214. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 215. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 218. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 219. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 220. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 221. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 222. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 223. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. CANADA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SPRAYS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ANALGESICS, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONES, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BUCCAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Buccal Drug Delivery Systems market report include:
  • GlaxoSmithKline plc
  • Novartis AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Bausch Health Companies Inc.
  • BioDelivery Sciences International, Inc.
  • Roche Holding AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.18 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Buccal Cavity Devices Market by Product Type (Buccal Film, Buccal Patch, Buccal Tablet), Drug Class (Hormones, Local Anesthetics, Nicotine), Technology, End User, Application - Global Forecast 2025-2030 - Product Image

Buccal Cavity Devices Market by Product Type (Buccal Film, Buccal Patch, Buccal Tablet), Drug Class (Hormones, Local Anesthetics, Nicotine), Technology, End User, Application - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Buccal Drug Delivery Systems Market (2024 Edition): Analysis By Product (Sublingual Films, Buccal Tablets and Lozenges, Oral Sprays), By Application, By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 257 Pages
  • Global
From
Buccal Drug Delivery Systems - Global Strategic Business Report - Product Image

Buccal Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 368 Pages
  • Global
From
Buccal Drug Delivery System Market Report 2025 - Product Image

Buccal Drug Delivery System Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Transmucosal Drug Delivery Systems - Global Strategic Business Report - Product Image

Transmucosal Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From

About the Buccal Drug Market

The Buccal Drug Delivery market is a subset of Transdermal and Transmucosal Drug Delivery, which refers to the administration of drugs through the skin or mucous membranes. Buccal Drug Delivery involves the administration of drugs through the buccal mucosa, which is the mucous membrane lining the inside of the cheeks. This method of drug delivery is advantageous because it is non-invasive, has a rapid onset of action, and is suitable for both local and systemic drug delivery. It is also advantageous for drugs that are not suitable for other routes of administration, such as those that are rapidly metabolized in the gastrointestinal tract. Some companies in the Buccal Drug Delivery market include 3M Drug Delivery Systems, Aquestive Therapeutics, Inc., and Zosano Pharma Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.